RA Capital Management, L.P. 13D/13G Filings for LENZ Therapeutics, Inc. (LENZ)

RA Capital Management, L.P. 13D and 13G filings for LENZ Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-09
4:19 pm
Purchase
2025-05-0713DLENZ Therapeutics, Inc.
LENZ
RA Capital Management, L.P.4,260,606
15.100%
4,260,606increase
(New Position)
Filing